BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2721804)

  • 1. Acetylator phenotype in psoriasis.
    Jiménez-Nieto LC; Ladero JM; Fernández-Gundín MJ; Robledo A
    Dermatologica; 1989; 178(3):136-7. PubMed ID: 2721804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylator polymorphism in rheumatoid arthritis.
    Ladero JM; Andres MP; Bañares A; Fernández B; Hernández C; Benítez J
    Eur J Clin Pharmacol; 1993; 45(3):279-81. PubMed ID: 8276055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylator polymorphism in Parkinson's disease.
    Ladero JM; Jimenez FJ; Benitez J; Fernandez-Gundin MJ; Martinez C; Llerena A; Cobaleda J; Muñoz JJ
    Eur J Clin Pharmacol; 1989; 37(4):391-3. PubMed ID: 2598972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic acetylator polymorphism in breast cancer patients.
    Ladero JM; Fernández MJ; Palmeiro R; Muñoz JJ; Jara C; Lázaro C; Pérez-Manga G
    Oncology; 1987; 44(6):341-4. PubMed ID: 3684174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic acetylator phenotype in bladder cancer patients.
    Ladero JM; Kwok CK; Jara C; Fernandez L; Silmi AM; Tapia D; Uson AC
    Ann Clin Res; 1985; 17(3):96-9. PubMed ID: 4051447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylator polymorphism in Alzheimer's disease.
    Ladero JM; Barquero MS; Coria F; Molina JA; Jiménez-Jiménez FJ; Benítez J
    Eur J Med; 1993 May; 2(5):281-3. PubMed ID: 8252158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphic N-acetylation of sulfamethazine and benzidine by human liver: implication for cancer risk?
    Peters JH; Gordon GR; Lin E; Green CE; Tyson CA
    Anticancer Res; 1990; 10(1):225-9. PubMed ID: 2334132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically determined variability in acetylation and oxidation. Therapeutic implications.
    Clark DW
    Drugs; 1985 Apr; 29(4):342-75. PubMed ID: 2859977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylation.
    Weber WW
    Birth Defects Orig Artic Ser; 1990; 26(1):43-65. PubMed ID: 2224079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylator polymorphism in multiple sclerosis.
    Ladero JM; Arroyo R; De Andrés C; Jiménez-Jiménez FJ; Molina JA; Varela de Seijas E; Giménez-Roldán S; Benítez J
    Acta Neurol Scand; 1994 Feb; 89(2):102-4. PubMed ID: 8191871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Distribution of acetylator phenotypes in the normal Moscow city population and in chronic alcoholism].
    Lil'in ET; Korsunskaia MP; Meksin VA; Drozdov ES; Nazarov VV
    Genetika; 1984 Sep; 20(9):1557-9. PubMed ID: 6542045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of the slow acetylator phenotype with bladder cancer.
    Evans DA; Eze LC; Whibley EJ
    J Med Genet; 1983 Oct; 20(5):330-3. PubMed ID: 6644762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug acetylation and expression of lupus erythematosus.
    Marsden JR; Mason GG; Coburn PR; Rawlins MD; Shuster S
    Eur J Clin Pharmacol; 1985; 28(4):387-90. PubMed ID: 4029245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylation polymorphism and leprosy.
    Eze LC; Okpogba AN; Ogan AU
    Biochem Genet; 1990 Feb; 28(1-2):1-7. PubMed ID: 2344344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between the acetylator and the sparteine hydroxylation polymorphisms.
    Harmer D; Evans DA; Eze LC; Jolly M; Whibley EJ
    J Med Genet; 1986 Apr; 23(2):155-6. PubMed ID: 3712391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylator phenotype and congenital malformations.
    Stoll C; Roth MP; Dott B; Doumit N; Alembik Y; Welsch M; Imbs JL
    Eur J Clin Pharmacol; 1989; 36(2):151-3. PubMed ID: 2721540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of microalbuminuria with slow acetylator phenotype in type 1 diabetes mellitus.
    Madácsy L; Szórády I; Sánta A; Barkai L; Vámosi I
    Child Nephrol Urol; 1992; 12(4):192-6. PubMed ID: 1473091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-acetylation phenotyping with sulphadimidine in a Turkish population.
    Bozkurt A; Basci NE; Kalan S; Tuncer M; Kayaalp SO
    Eur J Clin Pharmacol; 1990; 38(1):53-6. PubMed ID: 2328748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between acetylator phenotype and intensity of the hypoglycaemic effect of a suplhonamide preparation in children with insulin-dependent diabetes.
    Hadasová E; Brysová V; Utĕsený J; Macků M
    Bratisl Lek Listy; 1991 Dec; 92(12):609-14. PubMed ID: 1806177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphically acetylated aminoglutethimide in humans.
    Coombes RC; Foster AB; Harland SJ; Jarman M; Nice EC
    Br J Cancer; 1982 Sep; 46(3):340-5. PubMed ID: 7126424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.